FUJISAWA SHOJI CO.,LTD.
⚠️ High Risk
FEI: 1000385000 • Saitama, Saitama • JAPAN
FEI Number
1000385000
Location
Saitama, Saitama
Country
JAPANAddress
70-4 OI INARIZUKA KUMAGAYA-SHI, , Saitama, Saitama, Japan
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
MFR INSAN
The article is subject to refusal of admission pursuant to section 801(a)(1) in that the article appears to have been manufactured, processed, or packed under insanitary conditions.
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
INSANITARY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health.
POISONOUS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain a poisonous or deleterious substance which may render the article injurious to health. Contains:
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 3/6/2023 | 21HGY14PLUM, DRIED OR PASTE | 251POISONOUS | Division of West Coast Imports (DWCI) |
| 5/19/2017 | 16AHN99FISH, N.E.C. | 249FILTHY | Division of West Coast Imports (DWCI) |
| 5/19/2017 | 16AHN99FISH, N.E.C. | 249FILTHY | Division of West Coast Imports (DWCI) |
| 4/15/2015 | 16AGT01ANCHOVY | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 4/15/2015 | 16AGT01ANCHOVY | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 6/28/2012 | 16AGT01ANCHOVY | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 6/28/2012 | 16AGH33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.) | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 6/8/2012 | 16AGT01ANCHOVY | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 6/8/2012 | 16AGT01ANCHOVY | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 6/8/2012 | 16AGT01ANCHOVY | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 6/8/2012 | 16AGH01ANCHOVY | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 6/8/2012 | 16AGH01ANCHOVY | 308MFR INSAN | Los Angeles District Office (LOS-DO) |
| 5/21/2008 | 16AGH33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.) | 306INSANITARY | Atlanta District Office (ATL-DO) |
| 7/17/2007 | 16AGH33SARDINES (BRISLING, SPRATS, PILCHARDS, ETC.) | 306INSANITARY | Atlanta District Office (ATL-DO) |
Frequently Asked Questions
What is FUJISAWA SHOJI CO.,LTD.'s FDA import refusal history?
FUJISAWA SHOJI CO.,LTD. (FEI: 1000385000) has 14 FDA import refusal record(s) in our database, spanning from 7/17/2007 to 3/6/2023.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. FUJISAWA SHOJI CO.,LTD.'s FEI number is 1000385000.
What types of violations has FUJISAWA SHOJI CO.,LTD. received?
FUJISAWA SHOJI CO.,LTD. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about FUJISAWA SHOJI CO.,LTD. come from?
All FDA import refusal data for FUJISAWA SHOJI CO.,LTD. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.